An assessment of IGFBP5 revealed that the greatest rate of CNVs is found in ovarian cancer, with over 25% of patients possessing either an increase or decrease in copy number of the IGFBP5 gene. The gene discussed is IGFBP5; the disease is ovarian cancer.